Heckmann Lowered to Hold at Jefferies Group (HEK)

Jefferies Group cut shares of Heckmann (NYSE: HEK) from a buy rating to a hold rating in a research note issued to investors on Thursday. The firm currently has $4.50 target price on the stock, down from their previous target price of $5.50.

“We are lowering our rating to HOLD from BUY. Following a weak 4Q12, activity in shales served by HEK looks sluggish into 1H13 and water services pricing is challenged. We are lowering our 2013 estimate and adopting a more conservative valuation posture.,” Jefferies Group’s analyst wrote.

Shares of Heckmann traded up 1.95% during mid-day trading on Thursday, hitting $3.66. Heckmann has a one year low of $2.60 and a one year high of $5.41. The stock’s 50-day moving average is currently $3.92. The company’s market cap is $573.5 million.

A number of other analysts have also recently weighed in on HEK. Analysts at Wedbush downgraded shares of Heckmann from a neutral rating to an underperform rating in a research note to investors on Monday, February 11th. They now have a $2.50 price target on the stock, down previously from $3.00. Analysts at Ladenburg Thalmann upgraded shares of Heckmann from a sell rating to a neutral rating in a research note to investors on Tuesday, January 8th. They now have a $3.75 price target on the stock, up previously from $2.75.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Google Spends $1 Billion To Purchase Waze
Google Spends $1 Billion To Purchase Waze
Apple Exploring Options In Net Radio
Apple Exploring Options In Net Radio
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Aaron Hernandez, New England Patriots Player has House Searched
Aaron Hernandez, New England Patriots Player has House Searched
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe